Abstract
The crude polysaccharide (SCP) extracted from Schisandra chinensis by hot water extraction and ethanol precipitation, was further fractionated by DEAE-cellulose and Sephacryl S-300 chromatography, giving a polysaccharide fraction named as SCP-BII. The molecular weight of SCP-BII was 23 kDa using HPGPC. Gas chromatography analysis suggested that SCP-BII was composed of rhamnose, arabinose, mannose, galactose, glucose and galacturonic acid with a ratio of 4.7:2.6:0.8:5.6:1:5.6. Pharmaceutical experiments showed SCP-BII administered in alloxan-induced diabetic mice can significantly reduce blood glucose levels and water intake, and increase the body weight of diabetic mice. The results suggest SCP-BII attenuated the diabetes-induced weight loss, polydipsia and hyperglycemia, and these improvements suggest that Schisandra chinensis could be considered as a potential anti-diabetic agent.
Keywords: Schisandra chinensis, polysaccharide, purification, hypoglycemic, alloxan, anti-diabetic agent
Letters in Organic Chemistry
Title: Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill
Volume: 6 Issue: 5
Author(s): Xiaoxv Gao, Xianjun Meng, Jihai Li and Haibin Tong
Affiliation:
Keywords: Schisandra chinensis, polysaccharide, purification, hypoglycemic, alloxan, anti-diabetic agent
Abstract: The crude polysaccharide (SCP) extracted from Schisandra chinensis by hot water extraction and ethanol precipitation, was further fractionated by DEAE-cellulose and Sephacryl S-300 chromatography, giving a polysaccharide fraction named as SCP-BII. The molecular weight of SCP-BII was 23 kDa using HPGPC. Gas chromatography analysis suggested that SCP-BII was composed of rhamnose, arabinose, mannose, galactose, glucose and galacturonic acid with a ratio of 4.7:2.6:0.8:5.6:1:5.6. Pharmaceutical experiments showed SCP-BII administered in alloxan-induced diabetic mice can significantly reduce blood glucose levels and water intake, and increase the body weight of diabetic mice. The results suggest SCP-BII attenuated the diabetes-induced weight loss, polydipsia and hyperglycemia, and these improvements suggest that Schisandra chinensis could be considered as a potential anti-diabetic agent.
Export Options
About this article
Cite this article as:
Gao Xiaoxv, Meng Xianjun, Li Jihai and Tong Haibin, Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill, Letters in Organic Chemistry 2009; 6 (5) . https://dx.doi.org/10.2174/157017809788681374
DOI https://dx.doi.org/10.2174/157017809788681374 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Depression Rises the Risk of Hypertension Incidence: Discussing the Link through the Ca2+/cAMP Signalling
Current Hypertension Reviews Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?
Current Pharmaceutical Design The Stable Isotope Use in the Exploration of Bioavailability and Metabolism of Magnesium
Current Nutrition & Food Science Atherosclerosis and Arterial Blood Pressure in Mice
Current Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Endothelial Activation. Sliding Door to Atherosclerosis
Current Pharmaceutical Design Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients who did not Respond Fully to Amlodipine Monotherapy¥
Current Vascular Pharmacology Functional Profiles of Human Umbilical Cord-Derived Adult Mesenchymal Stem Cells in Obese/Diabetic Versus Healthy Women
Current Diabetes Reviews Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?
Current Medicinal Chemistry Sympathetic Nervous System, Genes and Human Essential Hypertension
Current Neurovascular Research Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis
Current Vascular Pharmacology Diabetic Nephropathy: Causes and Managements
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The “Sympathetic” Kidney: Multiples Effects of Renal Sympathetic Nerve Ablation
Current Hypertension Reviews Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Development of Radiolabeled Compounds for Myocardial Perfusion Imaging
Current Pharmaceutical Design Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia
Medicinal Chemistry Monoamine Receptors in the Regulation of Feeding Behaviour and Energy Balance
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects
Current Drug Metabolism